The role of inorganic chemistry in the development of radiometal agents for cancer therapy

被引：92
作者：
Heeg, MJ
Jurisson, SS [1 ]
机构：
[1] Univ Missouri, Res Reactor, Columbia, MO 65211 USA
[2] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA
[3] Univ Missouri, Dept Chem, Columbia, MO 65211 USA
来源：
ACCOUNTS OF CHEMICAL RESEARCH | 1999年 / 32卷 / 12期
关键词：
D O I：
10.1021/ar980002c
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：1053 / 1060
页数：8
相关论文
共 83 条
  • [1] Alberto R, 1997, RADIOCHIM ACTA, V79, P99
  • [2] ANDERSON CJ, 1995, J NUCL MED, V36, P2315
  • [3] Radioiodine and thyroid disease: The beginning
    Becker, DV
    Sawin, CT
    [J]. SEMINARS IN NUCLEAR MEDICINE, 1996, 26 (03) : 155 - 164
  • [4] SR-89 THERAPY - STRONTIUM KINETICS IN DISSEMINATED CARCINOMA OF THE PROSTATE
    BLAKE, GM
    ZIVANOVIC, MA
    MCEWAN, AJ
    ACKERY, DM
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1986, 12 (09): : 447 - 454
  • [5] BONIFACE GR, 1989, J NUCL MED, V30, P683
  • [6] BRADY LW, 1995, CANCER, V76, P2143, DOI 10.1002/1097-0142(19951115)76:10+<2143::AID-CNCR2820761339>3.0.CO
  • [7] 2-4
  • [8] BREITZ HB, 1992, J NUCL MED, V33, P1099
  • [9] BROCKMANN J, 1997, P 12 INT S RAD CHEM, P468
  • [10] Cleaves Margaret, 1903, MED REC, V64, P601
123456789